The World Market for Acyclic, Cyclanic, Cyclenic, Cycloterpenic, Aromatic Ethers, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives? What is the dollar value of these imports? How much do the imports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives, for each individual country. Chapter 4 does the same, but for imports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here, it is therefore estimated to have only a negligible level of trade in acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives (i.e. their market shares are close or equal to zero percent). 'Acyclic, Cyclanic, Cyclenic, Cycloterpenic, Aromatic Ethers, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives' is 51616.
Important Caveat: The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for the current year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, 'mad cow' disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism, and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the 'net loss' or 'net gain' due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.
Related Reports: This report was created for the market for acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives. Closely related reports published by ICON Group include the following:
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives? What is the dollar value of these imports? How much do the imports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives, for each individual country. Chapter 4 does the same, but for imports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here, it is therefore estimated to have only a negligible level of trade in acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives (i.e. their market shares are close or equal to zero percent). 'Acyclic, Cyclanic, Cyclenic, Cycloterpenic, Aromatic Ethers, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives' as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines 'acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives' is 51616.
Important Caveat: The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for the current year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, 'mad cow' disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism, and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the 'net loss' or 'net gain' due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.
Related Reports: This report was created for the market for acyclic, cyclanic, cyclenic, cycloterpenic, aromatic ethers, and their halogenated, sulfonated, nitrated, or nitrosated derivatives. Closely related reports published by ICON Group include the following:
- The World Market for Acetals, Hemiacetals, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
- The World Market for Acetone: A 2021 Global Trade Perspective
- The World Market for Acyclic Aldehydes without Other Oxygen Function: A 2021 Global Trade Perspective
- The World Market for Aldehyde-, Ketone-, and Quinone-Function Compounds: A 2021 Global Trade Perspective
- The World Market for Aromatic Ketones, Ketone Alcohols, Aldehydes, Phenols, Quinones, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
- The World Market for Butanone (Ethyl Methyl Ketone): A 2021 Global Trade Perspective
- The World Market for Camphor: A 2021 Global Trade Perspective
- The World Market for Esters of Inorganic Acids, Their Salts, and Their Halogenated, Sulfonated, Nitrated or Nitrosated Derivatives: A 2021 Global Trade Perspective
- The World Market for Ether-Alcohols, Ether-Phenols, Ether-Alcohol-Phenols; Alcohol, Ether, Ketone Peroxides; and Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
- The World Market for Ethers, Alcohol Peroxides, Ether Peroxides, Epoxides, Acetals and Hemiacetals, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
- The World Market for Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives of Aldehyde-Function Compounds Including Aldehydes, Cyclic Aldehyde Polymers, and Paraformaldehyde: A 2021 Global Trade Perspective
- The World Market for Methyloxirane (Propylene Oxide): A 2021 Global Trade Perspective
- The World Market for Oxirane (Ethylene Oxide): A 2021 Global Trade Perspective
- The World Market for Phosphoric Esters, Lactophosphates, Their Salts, and Their Halogenated, Sulfonated, Nitrated, or Nitrosated Derivatives: A 2021 Global Trade Perspective
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES EXPORT SUPPLIES IN 2021
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.1.1 EXECUTIVE SUMMARY
3.1.2 SOUTH AFRICA
3.1.3 UGANDA
3.2 ASIA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 PHILIPPINES
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CYPRUS
3.3.6 CZECH REPUBLIC
3.3.7 DENMARK
3.3.8 FINLAND
3.3.9 FRANCE
3.3.10 GERMANY
3.3.11 GREECE
3.3.12 HUNGARY
3.3.13 IRELAND
3.3.14 ITALY
3.3.15 KAZAKHSTAN
3.3.16 LATVIA
3.3.17 LITHUANIA
3.3.18 NORWAY
3.3.19 POLAND
3.3.20 PORTUGAL
3.3.21 ROMANIA
3.3.22 RUSSIA
3.3.23 SLOVAKIA
3.3.24 SLOVENIA
3.3.25 SPAIN
3.3.26 SWEDEN
3.3.27 SWITZERLAND
3.3.28 THE NETHERLANDS
3.3.29 THE UNITED KINGDOM
3.3.30 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 COSTA RICA
3.4.5 GUATEMALA
3.4.6 MEXICO
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.7.1 EXECUTIVE SUMMARY
3.7.2 AZERBAIJAN
3.7.3 ISRAEL
3.7.4 JORDAN
3.7.5 QATAR
3.7.6 SAUDI ARABIA
3.7.7 THE UNITED ARAB EMIRATES
3.7.8 TURKEY
4 IMPORTS
4.1 AFRICA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 CONGO (FORMERLY ZAIRE)
4.1.4 COTE D'IVOIRE
4.1.5 EGYPT
4.1.6 ETHIOPIA
4.1.7 MOROCCO
4.1.8 NAMIBIA
4.1.9 NIGERIA
4.1.10 SENEGAL
4.1.11 SOUTH AFRICA
4.1.12 ZAMBIA
4.2 ASIA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MALAYSIA
4.2.9 PHILIPPINES
4.2.10 SINGAPORE
4.2.11 SOUTH KOREA
4.2.12 SRI LANKA
4.2.13 TAIWAN
4.2.14 THAILAND
4.2.15 VIETNAM
4.3 EUROPE: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BOSNIA AND HERZEGOVINA
4.3.6 BULGARIA
4.3.7 CROATIA
4.3.8 CZECH REPUBLIC
4.3.9 DENMARK
4.3.10 ESTONIA
4.3.11 FINLAND
4.3.12 FRANCE
4.3.13 GEORGIA
4.3.14 GERMANY
4.3.15 GREECE
4.3.16 HUNGARY
4.3.17 IRELAND
4.3.18 ITALY
4.3.19 KAZAKHSTAN
4.3.20 LITHUANIA
4.3.21 LUXEMBOURG
4.3.22 MACEDONIA
4.3.23 MALTA
4.3.24 NORWAY
4.3.25 POLAND
4.3.26 PORTUGAL
4.3.27 ROMANIA
4.3.28 RUSSIA
4.3.29 SLOVAKIA
4.3.30 SLOVENIA
4.3.31 SPAIN
4.3.32 SWEDEN
4.3.33 SWITZERLAND
4.3.34 THE NETHERLANDS
4.3.35 THE UNITED KINGDOM
4.3.36 UKRAINE
4.4 LATIN AMERICA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 CHILE
4.4.6 COLOMBIA
4.4.7 ECUADOR
4.4.8 GUATEMALA
4.4.9 HONDURAS
4.4.10 MEXICO
4.4.11 NICARAGUA
4.4.12 PARAGUAY
4.4.13 PERU
4.4.14 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 DOMINICAN REPUBLIC
4.5.4 JAMAICA
4.5.5 THE UNITED STATES
4.6 OCEANIA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 ISRAEL
4.7.4 JORDAN
4.7.5 KUWAIT
4.7.6 OMAN
4.7.7 PAKISTAN
4.7.8 QATAR
4.7.9 TURKEY
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES EXPORT SUPPLIES IN 2021
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.1.1 EXECUTIVE SUMMARY
3.1.2 SOUTH AFRICA
3.1.3 UGANDA
3.2 ASIA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 INDONESIA
3.2.6 JAPAN
3.2.7 MALAYSIA
3.2.8 PHILIPPINES
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CYPRUS
3.3.6 CZECH REPUBLIC
3.3.7 DENMARK
3.3.8 FINLAND
3.3.9 FRANCE
3.3.10 GERMANY
3.3.11 GREECE
3.3.12 HUNGARY
3.3.13 IRELAND
3.3.14 ITALY
3.3.15 KAZAKHSTAN
3.3.16 LATVIA
3.3.17 LITHUANIA
3.3.18 NORWAY
3.3.19 POLAND
3.3.20 PORTUGAL
3.3.21 ROMANIA
3.3.22 RUSSIA
3.3.23 SLOVAKIA
3.3.24 SLOVENIA
3.3.25 SPAIN
3.3.26 SWEDEN
3.3.27 SWITZERLAND
3.3.28 THE NETHERLANDS
3.3.29 THE UNITED KINGDOM
3.3.30 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 COSTA RICA
3.4.5 GUATEMALA
3.4.6 MEXICO
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IN 2021
3.7.1 EXECUTIVE SUMMARY
3.7.2 AZERBAIJAN
3.7.3 ISRAEL
3.7.4 JORDAN
3.7.5 QATAR
3.7.6 SAUDI ARABIA
3.7.7 THE UNITED ARAB EMIRATES
3.7.8 TURKEY
4 IMPORTS
4.1 AFRICA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 CONGO (FORMERLY ZAIRE)
4.1.4 COTE D'IVOIRE
4.1.5 EGYPT
4.1.6 ETHIOPIA
4.1.7 MOROCCO
4.1.8 NAMIBIA
4.1.9 NIGERIA
4.1.10 SENEGAL
4.1.11 SOUTH AFRICA
4.1.12 ZAMBIA
4.2 ASIA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MALAYSIA
4.2.9 PHILIPPINES
4.2.10 SINGAPORE
4.2.11 SOUTH KOREA
4.2.12 SRI LANKA
4.2.13 TAIWAN
4.2.14 THAILAND
4.2.15 VIETNAM
4.3 EUROPE: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BOSNIA AND HERZEGOVINA
4.3.6 BULGARIA
4.3.7 CROATIA
4.3.8 CZECH REPUBLIC
4.3.9 DENMARK
4.3.10 ESTONIA
4.3.11 FINLAND
4.3.12 FRANCE
4.3.13 GEORGIA
4.3.14 GERMANY
4.3.15 GREECE
4.3.16 HUNGARY
4.3.17 IRELAND
4.3.18 ITALY
4.3.19 KAZAKHSTAN
4.3.20 LITHUANIA
4.3.21 LUXEMBOURG
4.3.22 MACEDONIA
4.3.23 MALTA
4.3.24 NORWAY
4.3.25 POLAND
4.3.26 PORTUGAL
4.3.27 ROMANIA
4.3.28 RUSSIA
4.3.29 SLOVAKIA
4.3.30 SLOVENIA
4.3.31 SPAIN
4.3.32 SWEDEN
4.3.33 SWITZERLAND
4.3.34 THE NETHERLANDS
4.3.35 THE UNITED KINGDOM
4.3.36 UKRAINE
4.4 LATIN AMERICA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 CHILE
4.4.6 COLOMBIA
4.4.7 ECUADOR
4.4.8 GUATEMALA
4.4.9 HONDURAS
4.4.10 MEXICO
4.4.11 NICARAGUA
4.4.12 PARAGUAY
4.4.13 PERU
4.4.14 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 DOMINICAN REPUBLIC
4.5.4 JAMAICA
4.5.5 THE UNITED STATES
4.6 OCEANIA: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: ACYCLIC, CYCLANIC, CYCLENIC, CYCLOTERPENIC, AROMATIC ETHERS, AND THEIR HALOGENATED, SULFONATED, NITRATED, OR NITROSATED DERIVATIVES IMPORTS IN 2021
4.7.1 EXECUTIVE SUMMARY
4.7.2 ARMENIA
4.7.3 ISRAEL
4.7.4 JORDAN
4.7.5 KUWAIT
4.7.6 OMAN
4.7.7 PAKISTAN
4.7.8 QATAR
4.7.9 TURKEY
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
